MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KAPLAN, A. S.
Right arrow Articles by BEN-PORAT, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KAPLAN, A. S.
Right arrow Articles by BEN-PORAT, T.

Molecular Pharmacology, Vol 4, 131-138, Copyright © 1968 by the American Society for Pharmacology and Experimental Therapeutics

Effect of 1,-beta-D-Arabinofuranosylcytosine on DNA Synthesis

I. In Normal Rabbit Kidney Cell Cultures

ALBERT S. KAPLAN 1, MCKAY BROWN 1, and TAMAR BEN-PORAT 1

1 Department of Microbiology, Research Laboratories, Albert Einstein Medical Center, Philadelphia, Pennsylvania 19141

Low concentrations of 1-beta-D-arabinofuranosylcytosine (Ara-C) inhibit the incorporation of cytidine aimd thymidine but stimulate the incorporation of deoxycytidine into the DNA of rabbit kidney cells. This stimulation is correlated with an increase in the level of activity of deoxycytidine kinase and with a consequent increase in the intracellular pool of phosphorylated deoxycytidine derived from the nucleoside in the medium.

Ara-C does not prevent the reduction of cytidine diphosphate to deoxycytidine diphosphate in rabbit kidney cells incubated in medium free of deoxycytidine. However, when small amounts of deoxycytidine are supplied to these cells, the drug is effective in inhibiting this reduction, probably as a result of an increase in the intracellular pool of deoxycytidine triphosphate and an ensuing negative feedback inhibition.

In agreement with observations made with other systems, in rabbit kidney cells the inhibition of DNA synthesis by the drug can be overcome by deoxycytidine. This reversal is due primarily to a successful competition of deoxycytidine with Ara-C at the level of phosphorylation, thereby preventing the accumulation of the effective inhibitor of DNA synthesis.

Note:
ACKNOWLEDGMENTS This investigation was supported by grants from the National Institutes of Health (AI-03362) and from the National Science Foundation (GB-4995), and by a U.S. Public Health Research Career Program Award (5-K3-AI-19,335) from the National Institute of Allergy and Infectious Diseases.

Submitted on August 21, 1967







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1968 by the American Society for Pharmacology and Experimental Therapeutics